Evidence map›Paper›PMID 38647527›Full record

ArticleThe ISME journal2024

Secondary messenger signalling influences Pseudomonas aeruginosa adaptation to sinus and lung environments.

Dilem Ruhluel, Lewis Fisher, Thomas E Barton, Hollie Leighton, Sumit Kumar, Paula Amores Morillo, Siobhan O'Brien, Joanne L Fothergill, Daniel R Neill

Open access · goldAbstract read
In one paragraph

Article in The ISME journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. The influence ofMicrobiology (Reading, England) · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Histamine Promotes Pseudomonas aeruginosa Biofilm Formation and Renders P. aeruginosa Biofilms More Resistant to Gentamicin and Azithromycin.Medical principles and practice : international journal of the Kuwait University, Health Science Centre · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Dilem RuhluelDepartment of Clinical Infection, Microbiology and Immunology, University of Liverpool, Ronald Ross Building, 8 West Derby Street, Liverpool, United Kingdom.
Lewis FisherWellcome Sanger Institute, Wellcome Genome Campus, Cambridge, United Kingdom.
Thomas E BartonDivision of Molecular Microbiology, University of Dundee, Dow Street, Dundee, United Kingdom.
Hollie LeightonDepartment of Clinical Infection, Microbiology and Immunology, University of Liverpool, Ronald Ross Building, 8 West Derby Street, Liverpool, United Kingdom.
Sumit KumarDivision of Molecular Microbiology, University of Dundee, Dow Street, Dundee, United Kingdom.
Paula Amores MorilloDepartment of Clinical Infection, Microbiology and Immunology, University of Liverpool, Ronald Ross Building, 8 West Derby Street, Liverpool, United Kingdom.
Siobhan O'BrienDepartment of Microbiology, Moyne Institute of Preventive Medicine, Trinity College, Dublin, 2, Ireland.
Joanne L FothergillDepartment of Clinical Infection, Microbiology and Immunology, University of Liverpool, Ronald Ross Building, 8 West Derby Street, Liverpool, United Kingdom.
Daniel R NeillDivision of Molecular Microbiology, University of Dundee, Dow Street, Dundee, United Kingdom.
University of Liverpool · GBUniversity of Dundee · GBMolecular Medicine Ireland · IEWellcome Sanger Institute · GB

Funding

CF FoundationNational Centre for the Replacement, Refinement and Reduction of Animals in Research NC/S001700/1NC3Rs NC/S00100/1Strategic Research Centre SRC 022UK Cystic Fibrosis TrustWellcome and Royal Society Sir Henry Dale 204457/Z/16/ZWellcome Trust
6 · The paper itself

Abstract

Pseudomonas aeruginosa is a cause of chronic respiratory tract infections in people with cystic fibrosis (CF), non-CF bronchiectasis, and chronic obstructive pulmonary disease. Prolonged infection allows the accumulation of mutations and horizontal gene transfer, increasing the likelihood of adaptive phenotypic traits. Adaptation is proposed to arise first in bacterial populations colonizing upper airway environments. Here, we model this process using an experimental evolution approach. Pseudomonas aeruginosa PAO1, which is not airway adapted, was serially passaged, separately, in media chemically reflective of upper or lower airway environments. To explore whether the CF environment selects for unique traits, we separately passaged PAO1 in airway-mimicking media with or without CF-specific factors. Our findings demonstrated that all airway environments-sinus and lungs, under CF and non-CF conditions-selected for loss of twitching motility, increased resistance to multiple antibiotic classes, and a hyper-biofilm phenotype. These traits conferred increased airway colonization potential in an in vivo model. CF-like conditions exerted stronger selective pressures, leading to emergence of more pronounced phenotypes. Loss of twitching was associated with mutations in type IV pili genes. Type IV pili mediate surface attachment, twitching, and induction of cAMP signalling. We additionally identified multiple evolutionary routes to increased biofilm formation involving regulation of cyclic-di-GMP signalling. These included the loss of function mutations in bifA and dipA phosphodiesterase genes and activating mutations in the siaA phosphatase. These data highlight that airway environments select for traits associated with sessile lifestyles and suggest upper airway niches support emergence of phenotypes that promote establishment of lung infection.

Indexed as

Adaptation, PhysiologicalBiofilmsPseudomonas aeruginosaPseudomonas InfectionsAnimalsAnti-Bacterial AgentsCyclic GMPCystic FibrosisFimbriae, BacterialHumansLungMiceMutationPhenotypeSecond Messenger SystemsAnti-Bacterial Agentsbis(3',5')-cyclic diguanylic acidCyclic GMPcyclic-di-GMPcystic fibrosisPseudomonas aeruginosarespiratory tract infectionwithin-host evolution

Identifiers

PMID38647527
PMCPMC11102083
OpenAlexW4394998507

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.